Skip to main content
Log in

Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty

  • Knee Arthroplasty
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Introduction

Reducing allogeneic blood transfusions remains a challenge in total knee arthroplasty. Patients with preoperative anemia have a particularly high risk for perioperative blood transfusions.

Materials and methods

176 anemic patients (Hb < 13.5 g/dl) undergoing total knee replacement were prospectively evaluated to compare the effect of a perioperative cell saver (26 patients), intraoperative fibrin sealants (5 ml Evicel®, Johnson & Johnson Wound Management, Ethicon, Somerville, NJ) (45 patients), preoperative autologous blood donation (PABD) (21 patients), the combination of fibrin sealants and preoperative autologous blood donation (44) and no intervention (40 patients) on perioperative blood loss and transfusion requirements.

Results

All protocols resulted in significant reduction of allogeneic blood transfusions. Transfusion rates were similar with the use of PABD (19 %), Evicel® (18 %), and cell saver (19 %), all significantly lower than the control group (38 %, p < 0.05). Combining Evicel® with PABD resulted in significantly higher wastage of autologous units (p < 0.05) with no significant reduction in allogeneic transfusion rate (14 %). The use of fibrin sealant resulted in a significant reduction of blood loss compared to the PABD group (603 vs. 810 ml, p < 0.005) as well as the control group (603 vs. 822 ml, p < 0.005).

Conclusions

While PABD proved to be the most cost-effective treatment option in anemic patients, fibrin sealants and cell saver show similar reduction in allogeneic transfusion rates compared to controls. The combination of fibrin sealants and PABD is not cost-effective and increases the number of wasted units.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Spahn DR (2010) Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 113(2):482–495. doi:10.1097/ALN.0b013e3181e08e97

    Article  PubMed  Google Scholar 

  2. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W (2012) Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplast 27(6):961–967. doi:10.1016/j.arth.2011.10.008

    Article  Google Scholar 

  3. Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P (2012) Estimating the transfusion risk following total knee arthroplasty. Orthopedics 35(10):e1465–e1471. doi:10.3928/01477447-20120919-13

    Article  PubMed  Google Scholar 

  4. Kim S, Altneu E, Monsef JB, King EA, Sculco TP, Boettner F (2011) Nonanemic patients do not benefit from autologous blood donation before total knee replacement. HSS J: Musculoskelet J Hosp Special Surg 7(2):141–144. doi:10.1007/s11420-011-9200-9

    Article  Google Scholar 

  5. Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A(2):216–220

    PubMed  Google Scholar 

  6. Husted H, Holm G, Jacobsen S (2008) Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients. Acta Orthop 79(2):168–173. doi:10.1080/17453670710014941

    Article  PubMed  Google Scholar 

  7. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR (2011) Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378(9800):1396–1407. doi:10.1016/S0140-6736(11)61381-0

    Article  PubMed  Google Scholar 

  8. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81(1):2–10

    CAS  PubMed  Google Scholar 

  9. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE (2004) Risks associated with blood transfusion after total knee arthroplasty. J Arthroplast 19(3):281–287

    Article  Google Scholar 

  10. Sinclair KC, Clarke HD, Noble BN (2009) Blood management in total knee arthroplasty: a comparison of techniques. Orthopedics 32(1):19

    Article  PubMed  Google Scholar 

  11. Bern MM, Bierbaum BE, Katz JN, Losina E (2006) Autologous blood donation and subsequent blood use in patients undergoing total knee arthroplasty. Transfus Med 16(5):313–319. doi:10.1111/j.1365-3148.2006.00701.x

    Article  CAS  PubMed  Google Scholar 

  12. Forgie MA, Wells PS, Laupacis A, Fergusson D (1998) Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International study of perioperative transfusion (ISPOT) Investigators. Arch Intern Med 158(6):610–616

    Article  CAS  PubMed  Google Scholar 

  13. Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D (2002) Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD003602. doi:10.1002/14651858.CD003602

  14. Sculco TP, Gallina J (1999) Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics 22(1 Suppl):s129–s134

    CAS  PubMed  Google Scholar 

  15. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL (2000) Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 82(1):89–100

    CAS  PubMed  Google Scholar 

  16. Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 357:50–59

    Article  PubMed  Google Scholar 

  17. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B (1993) The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 33(7):544–551

    Article  CAS  PubMed  Google Scholar 

  18. Thoms RJ, Marwin SE (2009) The role of fibrin sealants in orthopaedic surgery. J Am Acad Orthop Surg 17(12):727–736

    PubMed  Google Scholar 

  19. Carless PA, Henry DA, Anthony DM (2003) Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev (2):CD004171. doi:10.1002/14651858.CD004171

  20. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 81(11):1580–1588

    CAS  PubMed  Google Scholar 

  21. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD (2001) Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 83-A(10):1503–1505

    CAS  PubMed  Google Scholar 

  22. Sculco TP (1998) Global blood management in orthopaedic surgery. Clin Orthop Relat Res 357:43–49

    Article  PubMed  Google Scholar 

  23. Wang GJ, Goldthwaite CA Jr, Burks S, Crawford R, Spotnitz WD (2003) Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 13(5):399–411

    Article  PubMed  Google Scholar 

  24. Everts PA, Devilee RJ, Oosterbos CJ, Mahoney CB, Schattenkerk ME, Knape JT, van Zundert A (2007) Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA 15(7):888–894. doi:10.1007/s00167-007-0296-x

    Article  Google Scholar 

  25. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T (2006) Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 14(2):117–121

    CAS  Google Scholar 

  26. Flynn JC, Metzger CR, Csencsitz TA (1982) Intraoperative autotransfusion (IAT) in spinal surgery. Spine 7(5):432–435

    Article  CAS  PubMed  Google Scholar 

  27. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (4):CD001888. doi:10.1002/14651858.CD001888.pub4

  28. Billote DB, Glisson SN, Green D, Wixson RL (2002) A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 84-A(8):1299–1304

    PubMed  Google Scholar 

  29. Heyse TJ, Haas SB, Drinkwater D, Lyman S, Kim HJ, Kahn BA, Figgie MP (2013) Intraarticular fibrinogen does not reduce blood loss in TKA: a randomized clinical trial. Clin Orthop Relat Res. doi:10.1007/s11999-013-3036-1

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Friedrich Boettner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bou Monsef, J., Buckup, J., Waldstein, W. et al. Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty. Arch Orthop Trauma Surg 134, 53–58 (2014). https://doi.org/10.1007/s00402-013-1876-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-013-1876-5

Keywords

Navigation